Treatment with beta-adrenostimulants.
D000316:Adrenergic alpha-Agonists / Q000009:adverse effects; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists